chr17-31356981-C-G
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001042492.3(NF1):c.7760C>G(p.Ser2587*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001042492.3 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:3
- -
PVS1, PS4_Supporting, PM2 -
- -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.S2587* pathogenic mutation (also known as c.7760C>G,c.7697C>G andp.S2566*) located in coding exon 53 of the NF1 gene, results from a C to G substitution at nucleotide position 7760. This changes the amino acid from a serine to a stop codon within coding exon 53. This mutation was detected in a72 year old who was suspected of having NF1 (Neurofibromatosistype 1), butdid not fully meet NIHdiagnosticcriteria (Griffiths S, et al.Fam. Cancer 2007 ; 6(1):21-34). In addition to the clinical data presented in the literature, since premature stop codons are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at